ArticleClinical case reports2026
Case Report of Rasmussen's Encephalitis With a Decade of Refractory Epilepsy and Hemispheric Atrophy.
Article in Clinical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report of Rasmussen's Encephalitis With a Decade of Refractory Epilepsy and Hemispheric Atrophy.Clinical case reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rasmussen's encephalitis (RE) is a rare, chronic inflammatory neurological disorder affecting one cerebral hemisphere and presenting with drug-resistant epilepsy, progressive hemiparesis, and cognitive decline. This case report describes the clinical course and management of a 21-year-old patient with refractory epilepsy and progressive neurological deterioration due to RE, followed over 12 years. The patient initially presented with persistent focal seizures characterized by automotor features, visual hallucinations, and postictal confusion, along with progressive right hemispheric atrophy and metabolic disturbances, including hypokalemia and bicarbonate deficits. Diagnosis was established through neuroimaging, revealing significant right hemispheric atrophy and EEG findings of frequent multifocal discharges. Management included immunomodulatory therapies, surgical intervention (right temporal lobectomy), and antiseizure medications. Despite partial seizure control, disease progression could not be arrested.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.